Literature DB >> 27749408

Kidney Tumor in a von Hippel-Lindau (VHL) Patient With Intensely Increased Activity on 68Ga-DOTA-TATE PET/CT.

Georgios Z Papadakis1, Corina Millo, Samira M Sadowski, Ulas Bagci, Nicholas J Patronas.   

Abstract

Renal and pancreatic cysts and tumors are the most common visceral manifestations of von Hippel-Lindau (VHL) disease, a heritable multisystem cancer syndrome characterized by development of a variety of malignant and benign tumors. We report a case of a VHL patient with multiple renal cystic and complex cystic/solid lesions. The patient underwent Ga-DOTA-TATE-PET/CT showing intensely increased activity by a solid lesion which demonstrated enhancement on both CT and MRI scans, raising high suspicion for malignancy. The presented case indicates application of SSTR-imaging using Ga-DOTA-conjugated peptides in VHL-patients and emphasizes the need for cautious interpretation of renal parenchyma Ga-DOTATATE activity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27749408      PMCID: PMC5099086          DOI: 10.1097/RLU.0000000000001393

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  11 in total

1.  Primary renal carcinoid tumor: A rare cystic renal neoplasm.

Authors:  Jung-Hee Yoon
Journal:  World J Radiol       Date:  2013-08-28

2.  Ga-68 Somatostatin Receptor PET/CT in von Hippel-Lindau Disease.

Authors:  Jong-Ryool Oh; Harshad Kulkarni; Cecilia Carreras; Georg Schalch; Jung-Joon Min; Richard P Baum
Journal:  Nucl Med Mol Imaging       Date:  2012-04-27

3.  68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease.

Authors:  Valentina Ambrosini; Davide Campana; Vincenzo Allegri; Giuseppe Opocher; Stefano Fanti
Journal:  Clin Nucl Med       Date:  2011-01       Impact factor: 7.794

Review 4.  CT and MR imaging for evaluation of cystic renal lesions and diseases.

Authors:  Cecil G Wood; LeRoy J Stromberg; Carla B Harmath; Jeanne M Horowitz; Chun Feng; Nancy A Hammond; David D Casalino; Lori A Goodhartz; Frank H Miller; Paul Nikolaidis
Journal:  Radiographics       Date:  2015 Jan-Feb       Impact factor: 5.333

Review 5.  Primary carcinoid tumors of the kidney.

Authors:  Frederico R Romero; Soroush Rais-Bahrami; Sompol Permpongkosol; Samson W Fine; Sahar Kohanim; Thomas W Jarrett
Journal:  J Urol       Date:  2006-12       Impact factor: 7.450

6.  Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation.

Authors:  Michael S Hofman; W F Eddie Lau; Rodney J Hicks
Journal:  Radiographics       Date:  2015 Mar-Apr       Impact factor: 5.333

Review 7.  Imaging features of von Hippel-Lindau disease.

Authors:  Rebecca S Leung; Sona V Biswas; Mark Duncan; Sheila Rankin
Journal:  Radiographics       Date:  2008 Jan-Feb       Impact factor: 5.333

Review 8.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

Review 9.  Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease.

Authors:  M Meister; P Choyke; C Anderson; U Patel
Journal:  Clin Radiol       Date:  2008-12-18       Impact factor: 2.350

Review 10.  von Hippel-Lindau disease: genetic, clinical, and imaging features.

Authors:  P L Choyke; G M Glenn; M M Walther; N J Patronas; W M Linehan; B Zbar
Journal:  Radiology       Date:  1995-03       Impact factor: 11.105

View more
  2 in total

1.  Fibrous Dysplasia Mimicking Malignancy on 68Ga-DOTATATE PET/CT.

Authors:  Georgios Z Papadakis; Corina Millo; Samira M Sadowski; Apostolos H Karantanas; Ulas Bagci; Nicholas J Patronas
Journal:  Clin Nucl Med       Date:  2017-03       Impact factor: 7.794

2.  The utility of 68Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors.

Authors:  Jasmine Shell; Amit Tirosh; Corina Millo; Samira M Sadowski; Yasmine Assadipour; Patience Green; Dhaval Patel; Naris Nilubol; Electron Kebebew
Journal:  Eur J Radiol       Date:  2018-11-22       Impact factor: 3.528

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.